Department of Endocrinology, Shenzhen Luohu People's Hospital, Shenzhen 518001, China.
Yi Chuan. 2022 Nov 20;44(11):1072-1078. doi: 10.16288/j.yczz.22-197.
Primary aldosteronism (PA) is a disease characterized by hypertension and hypokalemia due to the excessive aldosterone secretion from the adrenal cortex, which leads to the retention of both water and sodium, and the inhibition of the renin-angiotensin system as well. Familial hyperaldosteronism type II (FH-II) is known as an autosomal dominant hereditary disease, which is a scarce cause of PA. In this report, we cllected the clinical data of a patient with repeated hypertension and hypokalemia of uncertain diagnosis since 2014. Nevertheless, we discovered by genetic sequencing in 2021 that the CLCN2 and WFS1 gene mutation of the patient, whose mother belongs to heterozygote genotype and father belongs to wild-type genotype. Combined with a series of endocrine function tests and imaging studies, the patient was finally certified her suffering from FH-II and WFS1 gene mutation. By summarizing and analyzing the characteristics and genetic test results of this case, we recommended gene sequencing for patients with PA whose etiology is difficult to be determined clinically. This case also provides new clinical data for subsequent genetic studies of the disease.
原发性醛固酮增多症(PA)是一种由肾上腺皮质过量分泌醛固酮引起的疾病,其特征是高血压和低钾血症,导致水和钠潴留,并抑制肾素-血管紧张素系统。家族性醛固酮增多症 II 型(FH-II)是一种常染色体显性遗传性疾病,是 PA 的罕见病因。在本报告中,我们收集了一位自 2014 年以来反复出现高血压和低钾血症的患者的临床数据,尽管病因尚未明确。然而,我们在 2021 年通过基因测序发现,患者的 CLCN2 和 WFS1 基因突变,其母亲为杂合子基因型,父亲为野生型基因型。结合一系列内分泌功能检查和影像学研究,最终确诊患者患有 FH-II 和 WFS1 基因突变。通过总结和分析该病例的特点和基因检测结果,我们建议对病因难以临床确定的 PA 患者进行基因测序。该病例也为该疾病的后续遗传研究提供了新的临床数据。